‘Universal and persistent’: Surfaces near nursing home beds may harbor coronavirus for days
By
Alicia Lasek
Nov 16, 2021
Surfaces in 90% of COVID-19 patients’ rooms were contaminated with the SARS-CoV-2 virus, most commonly bed and TV remote controls, nurse call buttons, window sills and door knobs, investigators say.
CDC: Prepare for rebound in TB cases post-pandemic
By
Alicia Lasek
Mar 21, 2022
A 20% decline in tuberculosis cases in 2020 may be followed by an uptick once the COVID-19 pandemic wanes, according to CDC investigators. Clinicians should be prepared to detect cases and control spread,...
Orthostatic intolerance common in post-acute patients, signaling need for clinical workup
By
Alicia Lasek
Sep 02, 2021
Older rehabilitation patients should be assessed for symptoms of orthostatic intolerance upon admission, a new study suggests.
Survey: Overuse of constipation drugs suggests need for more clinician input
By
Alicia Lasek
Oct 07, 2022
Half of patients who use over-the-counter drugs for constipation do not use them as recommended, and many do not discuss their problem with a physician, a new survey finds.
In-home COPD management program cuts 30-day acute-care readmissions
By
Alicia Lasek (f3)
Jun 29, 2022
Thirty-day readmission rates were 12% for post-acute COPD participants in an at-home pulmonary rehab program, and 22% for those without the intervention, a new study finds.
Bone health intervention cuts fracture risk in men treated for prostate cancer: study
By
Alicia Lasek
Apr 05, 2022
Early intervention with bone mineral density screening may help prevent major fractures in older men treated with androgen deprivation therapy, investigators say.
FDA expands use of remdesivir to skilled nursing, other non-hospital settings
By
Alicia Lasek
Jan 25, 2022
Remdesivir, the first FDA-approved COVID-19 drug, now can be used in adult and pediatric patients with mild-to moderate COVID-19 illness at high risk of progressing to severe disease, the agency has announced.
Monoclonal antibodies excel in treating COVID-19 breakthrough cases, Mayo Clinic says
By
Alicia Lasek
Nov 19, 2021
Monoclonal antibody treatment lowers the odds of hospitalization by 77% in patients with COVID-19 breakthrough infections, investigators say. These SARS-CoV-2 reinfections have become more common in long-term...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...